Denali Therapeutics Shares Decline 14% on Proposed Stock Offering
marketwatch.com
news
2022-10-18 21:20:00

By Stephen Nakrosis Shares of Denali Therapeutics Inc. declined in Tuesday's after-hours session, following news the company plans a $250 million underwritten public offering of its common stock. At 4:43 p.m. ET, the biopharmaceutical company's shares had fallen 14.66% to $28. The stock finished the day's regular session with a 2.64% loss, closing at $32.81 per share. Denali said it is "developing a broad portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases.
